These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7584921)

  • 21. Blockade of brain "ouabain" prevents sympathoexcitatory and pressor responses to high sodium in SHR.
    Huang BS; Leenen FH
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H103-8. PubMed ID: 8760164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain ouabain-like activity and the sympathoexcitatory and pressor effects of central sodium in rats.
    Huang BS; Harmsen E; Yu H; Leenen FH
    Circ Res; 1992 Nov; 71(5):1059-66. PubMed ID: 1394869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ouabain-like compound in the rostral ventrolateral medulla in rats.
    Teruya H; Yamazato M; Muratani H; Sakima A; Takishita S; Terano Y; Fukiyama K
    J Clin Invest; 1997 Jun; 99(11):2791-8. PubMed ID: 9169510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with digibind. Stoichiometry and its implications.
    Krep HH; Graves SW; Price DA; Lazarus M; Ensign A; Soszynski PA; Hollenberg NK
    Am J Hypertens; 1996 Jan; 9(1):39-46. PubMed ID: 8834705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of free digoxin-like immunoreactive components of oriental medicines Dan Shen and Lu-Shen-Wan by the Fab fragment of antidigoxin antibody (Digibind).
    Dasgupta A; Szelei-Stevens KA
    Am J Clin Pathol; 2004 Feb; 121(2):276-81. PubMed ID: 14983943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
    De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R
    J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
    Wenger TL
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain Na+,K+-ATPase isozyme activity and protein expression in ouabain-induced hypertension.
    Kent MA; Huang BS; Van Huysse JW; Leenen FH
    Brain Res; 2004 Aug; 1018(2):171-80. PubMed ID: 15276875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation.
    Huang BS; Kudlac M; Kumarathasan R; Leenen FH
    Hypertension; 1999 Oct; 34(4 Pt 2):733-8. PubMed ID: 10523351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Clin Exp Immunol; 1988 Dec; 74(3):489-93. PubMed ID: 3233793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The augmented blood pressure response to chronic angiotensin II infusion in partially nephrectomized rats.
    Yasujima M; Kanazawa M; Yoshida K; Kohzuki M; Watanabe H; Hiwatari M; Sato T; Abe K
    Tohoku J Exp Med; 1993 Apr; 169(4):271-7. PubMed ID: 8248917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of hypertension in a pyelonephritis-induced model: the effect of salt intake and inability of renal sodium handling.
    de Magalhães Sartim R; Fantinato Menegon L; de Almeida AR; Rocha Gontijo JA; Aline Boer P
    Ren Fail; 2006; 28(6):501-7. PubMed ID: 16928620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of renal papillae in the regulation of sodium excretion during acute elevation of renal perfusion pressure in the rat.
    Chen PS; Caldwell RM; Hsu CH
    Hypertension; 1984; 6(6 Pt 1):893-8. PubMed ID: 6519746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic effects of intact digoxin antibody and its Fab fragments in experimental hypertension.
    Mann JF; Miemietz R; Ganten U; Ritz E
    J Hypertens; 1987 Oct; 5(5):543-9. PubMed ID: 3429860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal and vascular nitric oxide system in reduced renal mass saline hypertension.
    Arranz C; Tomat A; Fellet A; García J; Balaszczuk AM; de los Angeles Costa M
    Nephron Physiol; 2003; 95(2):p36-42. PubMed ID: 14610322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ouabain- and central sodium-induced hypertension depend on the ventral anteroventral third ventricle region.
    Veerasingham SJ; Leenen FH
    Am J Physiol; 1999 Jan; 276(1):H63-70. PubMed ID: 9887018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin infusion induces endothelin-1-dependent hypertension in rats.
    Juan CC; Shen YW; Chien Y; Lin YJ; Chang SF; Ho LT
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E948-54. PubMed ID: 15226099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake.
    Fedorova OV; Kolodkin NI; Agalakova NI; Namikas AR; Bzhelyansky A; St-Louis J; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Apr; 23(4):835-42. PubMed ID: 15775789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoning.
    Brubacher JR; Lachmanen D; Ravikumar PR; Hoffman RS
    Toxicon; 1999 Jun; 37(6):931-42. PubMed ID: 10340832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.